249 related articles for article (PubMed ID: 31123029)
1. High activation of STAT5A drives peripheral T-cell lymphoma and leukemia.
Maurer B; Nivarthi H; Wingelhofer B; Pham HTT; Schlederer M; Suske T; Grausenburger R; Schiefer AI; Prchal-Murphy M; Chen D; Winkler S; Merkel O; Kornauth C; Hofbauer M; Hochgatterer B; Hoermann G; Hoelbl-Kovacic A; Prochazkova J; Lobello C; Cumaraswamy AA; Latzka J; Kitzwögerer M; Chott A; Janikova A; Pospíšilova Š; Loizou JI; Kubicek S; Valent P; Kolbe T; Grebien F; Kenner L; Gunning PT; Kralovics R; Herling M; Müller M; Rülicke T; Sexl V; Moriggl R
Haematologica; 2020; 105(2):435-447. PubMed ID: 31123029
[TBL] [Abstract][Full Text] [Related]
2. A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.
Bessette K; Lang ML; Fava RA; Grundy M; Heinen J; Horne L; Spolski R; Al-Shami A; Morse HC; Leonard WJ; Kelly JA
Blood; 2008 Jan; 111(1):344-50. PubMed ID: 17890450
[TBL] [Abstract][Full Text] [Related]
3. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B.
Verdier F; Rabionet R; Gouilleux F; Beisenherz-Huss C; Varlet P; Muller O; Mayeux P; Lacombe C; Gisselbrecht S; Chretien S
Mol Cell Biol; 1998 Oct; 18(10):5852-60. PubMed ID: 9742102
[TBL] [Abstract][Full Text] [Related]
4. STAT5BN642H is a driver mutation for T cell neoplasia.
Pham HTT; Maurer B; Prchal-Murphy M; Grausenburger R; Grundschober E; Javaheri T; Nivarthi H; Boersma A; Kolbe T; Elabd M; Halbritter F; Pencik J; Kazemi Z; Grebien F; Hengstschläger M; Kenner L; Kubicek S; Farlik M; Bock C; Valent P; Müller M; Rülicke T; Sexl V; Moriggl R
J Clin Invest; 2018 Jan; 128(1):387-401. PubMed ID: 29200404
[TBL] [Abstract][Full Text] [Related]
5. Enhanced T cell lymphoma in NOD.Stat5b transgenic mice is caused by hyperactivation of Stat5b in CD8+ thymocytes.
Chen B; Yi B; Mao R; Liu H; Wang J; Sharma A; Peiper S; Leonard WJ; She JX
PLoS One; 2013; 8(2):e56600. PubMed ID: 23457589
[TBL] [Abstract][Full Text] [Related]
6. BCR-ABL affects STAT5A and STAT5B differentially.
Schaller-Schönitz M; Barzan D; Williamson AJ; Griffiths JR; Dallmann I; Battmer K; Ganser A; Whetton AD; Scherr M; Eder M
PLoS One; 2014; 9(5):e97243. PubMed ID: 24836440
[TBL] [Abstract][Full Text] [Related]
7. Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function.
Lin JX; Li P; Liu D; Jin HT; He J; Ata Ur Rasheed M; Rochman Y; Wang L; Cui K; Liu C; Kelsall BL; Ahmed R; Leonard WJ
Immunity; 2012 Apr; 36(4):586-99. PubMed ID: 22520852
[TBL] [Abstract][Full Text] [Related]
8. Differential contributions of STAT5A and STAT5B to stress protection and tyrosine kinase inhibitor resistance of chronic myeloid leukemia stem/progenitor cells.
Casetti L; Martin-Lannerée S; Najjar I; Plo I; Augé S; Roy L; Chomel JC; Lauret E; Turhan AG; Dusanter-Fourt I
Cancer Res; 2013 Apr; 73(7):2052-8. PubMed ID: 23400594
[TBL] [Abstract][Full Text] [Related]
9. Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior.
Tang JZ; Zuo ZH; Kong XJ; Steiner M; Yin Z; Perry JK; Zhu T; Liu DX; Lobie PE
Endocrinology; 2010 Jan; 151(1):43-55. PubMed ID: 19966185
[TBL] [Abstract][Full Text] [Related]
10. Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation.
Hoelbl A; Kovacic B; Kerenyi MA; Simma O; Warsch W; Cui Y; Beug H; Hennighausen L; Moriggl R; Sexl V
Blood; 2006 Jun; 107(12):4898-906. PubMed ID: 16493008
[TBL] [Abstract][Full Text] [Related]
11. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells.
Lin JX; Mietz J; Modi WS; John S; Leonard WJ
J Biol Chem; 1996 May; 271(18):10738-44. PubMed ID: 8631883
[TBL] [Abstract][Full Text] [Related]
12. Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia.
Suske T; Sorger H; Manhart G; Ruge F; Prutsch N; Zimmerman MW; Eder T; Abdallah DI; Maurer B; Wagner C; Schönefeldt S; Spirk K; Pichler A; Pemovska T; Schweicker C; Pölöske D; Hubanic E; Jungherz D; Müller TA; Aung MMK; Orlova A; Pham HTT; Zimmel K; Krausgruber T; Bock C; Müller M; Dahlhoff M; Boersma A; Rülicke T; Fleck R; de Araujo ED; Gunning PT; Aittokallio T; Mustjoki S; Sanda T; Hartmann S; Grebien F; Hoermann G; Haferlach T; Staber PB; Neubauer HA; Look AT; Herling M; Moriggl R
J Clin Invest; 2024 Apr; 134(8):. PubMed ID: 38618957
[TBL] [Abstract][Full Text] [Related]
13. Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B.
Hennighausen L; Robinson GW
Genes Dev; 2008 Mar; 22(6):711-21. PubMed ID: 18347089
[TBL] [Abstract][Full Text] [Related]
14. Identification of STAT5A and STAT5B target genes in human T cells.
Kanai T; Seki S; Jenks JA; Kohli A; Kawli T; Martin DP; Snyder M; Bacchetta R; Nadeau KC
PLoS One; 2014; 9(1):e86790. PubMed ID: 24497979
[TBL] [Abstract][Full Text] [Related]
15. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
[TBL] [Abstract][Full Text] [Related]
16. STAT3 and STAT5 Signaling Thresholds Determine Distinct Regulation for Innate Receptor-Induced Inflammatory Cytokines, and
Hedl M; Sun R; Huang C; Abraham C
J Immunol; 2019 Dec; 203(12):3325-3338. PubMed ID: 31732533
[TBL] [Abstract][Full Text] [Related]
17. The STAT5b Linker Domain Mediates the Selectivity of Catechol Bisphosphates for STAT5b over STAT5a.
Gräb J; Berg A; Blechschmidt L; Klüver B; Rubner S; Fu DY; Meiler J; Gräber M; Berg T
ACS Chem Biol; 2019 Apr; 14(4):796-805. PubMed ID: 30835430
[TBL] [Abstract][Full Text] [Related]
18. Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells.
Jenks JA; Seki S; Kanai T; Huang J; Morgan AA; Scalco RC; Nath R; Bucayu R; Wit JM; Al-Herz W; Ramadan D; Jorge AA; Bacchetta R; Hwa V; Rosenfeld R; Nadeau KC
Clin Immunol; 2013 Aug; 148(2):227-36. PubMed ID: 23773921
[TBL] [Abstract][Full Text] [Related]
19. STAT5B: A Differential Regulator of the Life and Death of CD4
Majri SS; Fritz JM; Villarino AV; Zheng L; Kanellopoulou C; Chaigne-Delalande B; Grönholm J; Niemela JE; Afzali B; Biancalana M; Pittaluga S; Sun A; Cohen JL; Holland SM; O'Shea JJ; Uzel G; Lenardo MJ
J Immunol; 2018 Jan; 200(1):110-118. PubMed ID: 29187589
[TBL] [Abstract][Full Text] [Related]
20. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice.
Matsumoto A; Seki Y; Kubo M; Ohtsuka S; Suzuki A; Hayashi I; Tsuji K; Nakahata T; Okabe M; Yamada S; Yoshimura A
Mol Cell Biol; 1999 Sep; 19(9):6396-407. PubMed ID: 10454585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
